Manufacturer Drug Transparency Guidelines, Reporting Information and Templates

Drug Manufacturer Registration Template

• New or Updated Drug Manufacturer Registration Template 6-14-2019

Reporting Instructions & Template ~Drug Manufacturer Report-Diabetes and Over $40

NRS 439B.635 – Manufacturers of certain drugs to prepare and submit a report on or before April 1st annually. This refers to Nevada Drug Lists #2 and #4.

• Drug Manufacturer Reporting-Diabetes and Over $40 Instructions v09.20.2022
• Drug Manufacturer Reporting-Diabetes and Over $40 Template v09.20.2022 (2)

Reporting Instructions & Templates ~ Drug Manufacturer Significant Price Increase Report

NRS 439B.640 – Manufacturers of certain drugs that have undergone a significant price increase to submit report on or before April 1^st annually. This refers to Nevada Drug Lists #3 and #4.

• Drug Manufacturer Significant Price Increase Instructions v08.09.2022R
• Drug Manufacturer Significant Price Increase Reporting_Template v09.21.2022

Reporting Instructions & Template ~ Pharmaceutical Sales Representatives Registry

NRS 439B.660 – Manufacturers required to provide a complete list of pharmaceutical sales representatives active in Nevada, on or before January 15^th annually. A person who is not included on a current list submitted pursuant to subsection 1 shall not market prescription drugs on behalf of a manufacturer.

• Pharmaceutical Representatives Registration Instructions_v11.09.2022R
• Pharmaceutical Representatives Registry List Template v07.19.2018